Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have been assigned a consensus recommendation of “Moderate Buy” from the ten brokerages that are covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $101.25.

Several equities research analysts have issued reports on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Merit Medical Systems in a research note on Friday, March 27th. Canaccord Genuity Group raised their price objective on Merit Medical Systems from $93.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. Robert W. Baird set a $108.00 price objective on shares of Merit Medical Systems in a report on Tuesday, December 16th. Wall Street Zen cut shares of Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Sunday. Finally, Wells Fargo & Company lowered shares of Merit Medical Systems from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $95.00 to $78.00 in a research note on Thursday, February 26th.

Hedge Funds Weigh In On Merit Medical Systems

Hedge funds have recently made changes to their positions in the stock. Tudor Investment Corp ET AL acquired a new stake in Merit Medical Systems in the 3rd quarter valued at approximately $2,913,050,000. State Street Corp lifted its stake in Merit Medical Systems by 1.5% during the fourth quarter. State Street Corp now owns 2,231,048 shares of the medical instruments supplier’s stock worth $196,645,000 after purchasing an additional 32,459 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its position in shares of Merit Medical Systems by 12.7% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier’s stock worth $183,137,000 after buying an additional 234,682 shares during the period. Maverick Capital Ltd. boosted its position in shares of Merit Medical Systems by 8.4% during the second quarter. Maverick Capital Ltd. now owns 1,379,408 shares of the medical instruments supplier’s stock worth $128,947,000 after buying an additional 106,897 shares during the period. Finally, Wellington Management Group LLP grew its stake in shares of Merit Medical Systems by 7.0% in the fourth quarter. Wellington Management Group LLP now owns 1,327,013 shares of the medical instruments supplier’s stock valued at $116,963,000 after buying an additional 86,504 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Price Performance

Merit Medical Systems stock opened at $67.70 on Friday. The company has a current ratio of 4.34, a quick ratio of 2.95 and a debt-to-equity ratio of 0.46. The company has a 50-day moving average price of $75.42 and a 200 day moving average price of $81.59. Merit Medical Systems has a 12-month low of $66.34 and a 12-month high of $106.11. The stock has a market cap of $4.04 billion, a P/E ratio of 31.93, a PEG ratio of 1.95 and a beta of 0.64.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.08. The business had revenue of $393.94 million during the quarter, compared to analysts’ expectations of $390.77 million. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The business’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.93 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Sell-side analysts anticipate that Merit Medical Systems will post 3.37 earnings per share for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.